Nortriptyline Holsten (Nortriptyline Hydrochloride)

Nortriptyline, a tricyclic antidepressant, is used to manage several conditions related to mood regulation and nerve pain.

• Major depressive disorder: alleviates depressive symptoms, improves mood, sleep quality and concentration in adult patients.
• Neuropathic pain: reduces pain intensity and improves functional ability in patients with peripheral neuropathy.
• Chronic tension‑type headache: decreases frequency and severity of tension‑type headache episodes, providing better quality of life.

• Nortriptyline inhibits the reuptake of norepinephrine and serotonin at neuronal synapses, increasing their extracellular concentrations. The elevated neurotransmitter levels enhance descending inhibitory pathways in the central nervous system, which contributes to mood elevation and analgesic effects. Additionally, the drug blocks sodium channels and antagonizes certain muscarinic, histamine H1, and alpha‑adrenergic receptors, influencing its therapeutic and side‑effect profile.

Common side effects are generally mild to moderate and may diminish with continued therapy.

Common Side Effects

• Dry mouth: reduced salivation leading to a feeling of thirst.
• Constipation: slowed gastrointestinal motility.
• Drowsiness or sedation: increased sleepiness, especially at treatment initiation.
• Weight gain: gradual increase in body weight.
• Blurred vision: temporary visual disturbances.
• Dizziness: light‑headed sensation upon standing.

Serious or Rare Side Effects

• Cardiac arrhythmia: irregular heart rhythm, potentially life‑threatening.
• Seizures: heightened risk in predisposed individuals.
• Severe hypotension: marked drop in blood pressure.
• Agranulocytosis: dangerously low white‑blood‑cell count.
• Hepatic toxicity: liver enzyme elevations or injury.
• Neuroleptic malignant‑like syndrome: rare but severe reaction with fever and muscle rigidity.

Before initiating therapy, clinicians should evaluate patient history and monitor for specific risks.

• Cardiac assessment: obtain baseline ECG and review cardiac history.
• Concomitant CNS depressants: avoid or use with caution due to additive sedation.
• Elderly patients: start with lower doses and monitor for anticholinergic effects.
• Liver or kidney impairment: adjust dose based on organ function.
• Pregnancy and lactation: weigh potential benefits against unknown risks; discuss with obstetric specialist.
• Store at ambient temperature: keep below 25°C, retain in original packaging, protect from moisture and direct sunlight.

Nortriptyline may interact with several drug classes, altering its efficacy or safety.

Major Interactions (Avoid)

• MAO inhibitors: risk of severe hypertensive crisis or serotonin syndrome.
• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): can markedly increase nortriptyline plasma levels.
• Drugs that prolong QT interval: may precipitate cardiac arrhythmias.

Moderate Interactions (Monitor Closely):\n- Anticholinergic agents: additive dry mouth, constipation, urinary retention.

• CNS depressants (benzodiazepines, alcohol): enhanced sedation and respiratory depression.
• Diuretics: may potentiate orthostatic hypotension.
• Serotonergic agents (SSRIs, SNRIs): monitor for serotonin syndrome symptoms.